Meeting of the National Clinical Care Commission, 46549 [2019-18953]

Download as PDF Federal Register / Vol. 84, No. 171 / Wednesday, September 4, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Clinical Care Commission Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The National Clinical Care Commission (the Commission) will conduct a virtual meeting on September 27, 2019. The Commission is charged to evaluate and make recommendations to the U.S. Department of Health and Human Services (HHS) Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to awareness and clinical care for complex metabolic or autoimmune diseases that result from issues related to insulin that represent a significant disease burden in the United States, which may include complications due to such diseases. DATES: The meeting will take place on September 27, 2019, from 2:00 p.m. to approximately 5:30 p.m. Eastern Time (ET). SUMMARY: The meeting will be held online via webinar. To register to attend the meeting, please visit the registration website at https:// kauffmaninc.adobeconnect.com/nccc_ sept_2019/event/event_info.html. FOR FURTHER INFORMATION CONTACT: Clydette Powell, Designated Federal Officer, National Clinical Care Commission, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Suite LL–100, Rockville, MD 20852, telephone: 240–453–8239, Email: OHQ@ hhs.gov. Additional information may be obtained at https://health.gov/hcq/ national-clinical-care-commission.asp. SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act (Pub. L. 115–80) requires the HHS Secretary to establish the National Clinical Care Commission. The Commission consists of representatives of specific federal agencies and nonfederal individuals and entities who represent diverse disciplines and views. The Commission will evaluate and make recommendations to the HHS Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to awareness and clinical care for complex metabolic or autoimmune diseases that jbell on DSK3GLQ082PROD with NOTICES ADDRESSES: VerDate Sep<11>2014 19:08 Sep 03, 2019 Jkt 247001 result from issues related to insulin that represent a significant disease burden in the United States, which may include complications due to such diseases. The inaugural meeting of the Commission was held on October 31, 2018, during which non-federal Commission members were sworn-in, and various federal interagency efforts surrounding diabetes program were presented. This virtual meeting will consist of an update on the Data Call to federal agencies and Commission discussion on key topics for secondary research in support of the Report to Congress. The final meeting agenda will be available prior to the meeting at https:// health.gov/hcq/national-clinical-carecommission.asp. Public Participation at Meeting: The Commission invites public comment on issues related to the Commission’s charge. There will be no opportunity for oral comments at this virtual meeting. Written comments are welcome throughout the entire development process of the Commission’s recommendation and may be emailed to OHQ@hhs.gov, or by mail to the following address: Public Commentary, National Clinical Care Commission, 1101 Wootton Parkway, Suite LL–100, Rockville, MD 20852. Written comments should not exceed three pages in length. To virtually attend the Commission meeting, individuals must pre-register at the registration website at https:// kauffmaninc.adobeconnect.com/nccc_ sept_2019/event/event_info.html. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate the special accommodation when registering online or by notifying Jennifer Gillissen at jennifer.gillissen@ kauffmaninc.com by September 20. Authority: The National Clinical Care Commission is required under the National Clinical Care Commission Act (Pub. L. 115–80). The Commission is governed by provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C., App.) which sets forth standards for the formation and use of federal advisory committees. Dated: August 20, 2019. Donald Wright, Deputy Assistant Secretary for Health. [FR Doc. 2019–18953 Filed 9–3–19; 8:45 am] BILLING CODE 4150–32–P PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 46549 DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health, Office of Infectious Disease Policy. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services is hereby giving notice that a meeting is scheduled to be held for the National Vaccine Advisory Committee (NVAC). The meeting will be open to the public; public comment sessions will be held during the meeting. DATES: The meeting will be held on September 17 and 18, 2019. The meeting times and agenda will be posted on the NVAC website at https:// www.hhs.gov/vaccines/nvac/meetings/ index.html as soon as they become available. SUMMARY: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, The Great Hall, 200 Independence Avenue SW, Washington, DC 20201. The meeting can also be accessed through a live webcast on both days of the meeting. For more information, visit https://www.hhs.gov/webforms/nvac/ index.html. Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in a public comment session. Individuals who wish to attend the meeting and/or participate in a public comment session should register at https://www.hhs.gov/webforms/nvac/ index.html. Participants may also register by emailing nvac@hhs.gov or by calling (202) 795–7697 and providing their name, organization, and email address. ADDRESSES: Ann Aikin, Acting Designated Federal Officer, Office of Infectious Disease Policy, U.S. Department of Health and Human Services, Room L001, Switzer Building, 330 C Street SW, Washington, DC 20201. Phone: (202) 795–7697; email: nvac@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve FOR FURTHER INFORMATION CONTACT: E:\FR\FM\04SEN1.SGM 04SEN1

Agencies

[Federal Register Volume 84, Number 171 (Wednesday, September 4, 2019)]
[Notices]
[Page 46549]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18953]



[[Page 46549]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Clinical Care Commission

AGENCY: Office of Disease Prevention and Health Promotion, Office of 
the Assistant Secretary for Health, Office of the Secretary, Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Clinical Care Commission (the Commission) will 
conduct a virtual meeting on September 27, 2019. The Commission is 
charged to evaluate and make recommendations to the U.S. Department of 
Health and Human Services (HHS) Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to awareness and clinical care for complex metabolic or 
autoimmune diseases that result from issues related to insulin that 
represent a significant disease burden in the United States, which may 
include complications due to such diseases.

DATES: The meeting will take place on September 27, 2019, from 2:00 
p.m. to approximately 5:30 p.m. Eastern Time (ET).

ADDRESSES: The meeting will be held online via webinar. To register to 
attend the meeting, please visit the registration website at https://kauffmaninc.adobeconnect.com/nccc_sept_2019/event/event_info.html.

FOR FURTHER INFORMATION CONTACT: Clydette Powell, Designated Federal 
Officer, National Clinical Care Commission, U.S. Department of Health 
and Human Services, Office of the Assistant Secretary for Health, 
Office of Disease Prevention and Health Promotion, 1101 Wootton 
Parkway, Suite LL-100, Rockville, MD 20852, telephone: 240-453-8239, 
Email: [email protected]. Additional information may be obtained at https://health.gov/hcq/national-clinical-care-commission.asp.

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act 
(Pub. L. 115-80) requires the HHS Secretary to establish the National 
Clinical Care Commission. The Commission consists of representatives of 
specific federal agencies and non-federal individuals and entities who 
represent diverse disciplines and views. The Commission will evaluate 
and make recommendations to the HHS Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to awareness and clinical care for complex metabolic or 
autoimmune diseases that result from issues related to insulin that 
represent a significant disease burden in the United States, which may 
include complications due to such diseases.
    The inaugural meeting of the Commission was held on October 31, 
2018, during which non-federal Commission members were sworn-in, and 
various federal interagency efforts surrounding diabetes program were 
presented. This virtual meeting will consist of an update on the Data 
Call to federal agencies and Commission discussion on key topics for 
secondary research in support of the Report to Congress.
    The final meeting agenda will be available prior to the meeting at 
https://health.gov/hcq/national-clinical-care-commission.asp.
    Public Participation at Meeting: The Commission invites public 
comment on issues related to the Commission's charge. There will be no 
opportunity for oral comments at this virtual meeting. Written comments 
are welcome throughout the entire development process of the 
Commission's recommendation and may be emailed to [email protected], or by 
mail to the following address: Public Commentary, National Clinical 
Care Commission, 1101 Wootton Parkway, Suite LL-100, Rockville, MD 
20852. Written comments should not exceed three pages in length.
    To virtually attend the Commission meeting, individuals must pre-
register at the registration website at https://kauffmaninc.adobeconnect.com/nccc_sept_2019/event/event_info.html.
    Individuals who need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate the 
special accommodation when registering online or by notifying Jennifer 
Gillissen at [email protected] by September 20.
    Authority: The National Clinical Care Commission is required under 
the National Clinical Care Commission Act (Pub. L. 115-80). The 
Commission is governed by provisions of the Federal Advisory Committee 
Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets 
forth standards for the formation and use of federal advisory 
committees.

    Dated: August 20, 2019.
Donald Wright,
Deputy Assistant Secretary for Health.
[FR Doc. 2019-18953 Filed 9-3-19; 8:45 am]
BILLING CODE 4150-32-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.